Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.960
-0.030 (-1.00%)
At close: Aug 3, 2026, 4:00 PM EDT
2.980
+0.020 (0.68%)
After-hours: Aug 3, 2026, 6:16 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $145.9 million as of August 3, 2026. Its market cap has increased by 64.67% in one year.
Market Cap
145.90M
Enterprise Value
141.72M
1-Year Change
64.67%
Ranking
Category
Stock Price
$2.96
ChartMarket Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $145.90M, an increase of 104.34%. That is a compound annual growth rate of 9.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 145.90M | 63.93% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 154.31M |
| YD Bio | 152.59M |
| Milestone Pharmaceuticals | 151.02M |
| Korro Bio | 149.56M |
| Nkarta | 149.53M |
| Canton Strategic Holdings | 148.85M |
| Cibus | 147.32M |
| Indaptus Therapeutics | 146.08M |